Michael H. Mulroy

Chief Financial Officer, QUESTCOR PHARMACEUTICALS INC.

Companies

Lineage Cell TherapeuticsBoard member Oct 7, 2014 to now¹
Serina Therapeutics, Inc.Board member Nov 27, 2018 to Mar 13, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lineage Cell Therapeutics LCTX298,555 shares³$295.6K at $0.99Nov 22, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 22, 2024Bought 40,000 shares at $0.57 of Lineage Cell Therapeutics³
Mar 24, 2022Bought 7,000 shares at $1.40 of Lineage Cell Therapeutics⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLineage Cell Therapeutics, Board member
2
SEC EDGARSerina Therapeutics, Inc., Board member
3
SEC EDGARLineage Cell Therapeutics shares after the filing of Nov 22, 2024
4
SEC EDGARForm 4 filed Mar 25, 2022